1-Aminocyclopentane-1,2,4-tricarboxylic acids screening on glutamatergic and serotonergic systems

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 24, 2007, Pages 7581-7589

  Gelmi, Maria Luisa ^a   Caputo, Francesco ^a   Clerici, Francesca ^a   Pellegrino, Sara ^a   Giannaccini, Gino ^b   Betti, Laura ^b   Fabbrini, Laura ^b   Schmid, Lara ^b   Palego, Lionella ^b   Lucacchini, Antonio ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Aminocyclopentane 1,2,4 tricarboxylic acids; Chemical resolution; Glutamatergic receptors; Serotoninergic receptors

Indexed keywords

1 AMINOCYCLOPENTANE 1,2,4 TRICARBOXYLIC ACID; AMINO ACID; CARBOXYLIC ACID DERIVATIVE; GLUTAMIC ACID; METABOTROPIC RECEPTOR AGONIST; SEROTONIN; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DIASTEREOISOMER; ENANTIOSELECTIVITY; RECEPTOR BINDING; SEROTONINERGIC SYSTEM;

ANIMALS; CELLS, CULTURED; CYCLOPENTANES; DRUG EVALUATION, PRECLINICAL; HUMANS; MOLECULAR STRUCTURE; RATS; RECEPTORS, GLUTAMATE; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; STEREOISOMERISM; TRICARBOXYLIC ACIDS;

EID: 35348858056     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.09.004     Document Type: Article

References (38)

1. Danysz W., Parsons C.G., Bresink I., and Quack G. Drug News Perspect. 8 (1995) 261-277
2. Meldrum B.S. J. Nutr. 130 (2000) 1007S-1015S
3. Conn P.J., and Pin J.P. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 205-237
4. Schoepp D.D., Jane D.E., and Monn L.A. Neuropharmacology 38 (1999) 1431-1476
5. Schoepp D.D. J. Pharmacol. Exp. Ther. 299 (2001) 12-20
6. Thomas N.K., Woolley M.L., Miller J.C., Clark B.P., Harris J.R., Jane D.E., and Watkins J.C. Soc. Neurosci. Abstr. 28 (1998) 229.15
7. Ornstein P.L., Schoepp D.D., and Monn J.A. Curr. Pharm. Des. 1 (1995) 355-362
8. Jullian N., Brabet I., Pin J.-P., and Acher F.C. J. Med. Chem. 42 (1999) 1546-1555
9. Bertrand H.-O., Bessis A.-S., Pin J.-P., and Acher F.C. J. Med. Chem. 45 (2002) 3171-3183
10. Curry K., Peet M.J., Magnuson D.S.K., and McLennan H. J. Med. Chem. 31 (1988) 864-867
11. Ezquerra J., Yruretagoyena B., Avendano C., de la Cuesta E., Gonzales R., Prieto L., Pedregal C., Espada M., and Prowse W. Tetrahedron 51 (1995) 3271-3278
12. Tellier F.J., Acher F.C., Brabet I.N., Pin J.-P., Bockaert J., and Azerad R. Bioorg. Med. Chem. Lett. 5 (1995) 2627-2632
13. Acher F.C., Tellier F.J., Azerad R., Brabet I.N., Fagni L., and Pin J.-P.R. J. Med. Chem. 40 (1997) 3119-3129
14. Ma D., Ma J., and Dai L. Tetrahedron: Asymmetry 8 (1997) 825-827
15. Kozikowski A.P., Steensma D., Araldi G.L., Tuckmantel W., Wang S., Pshenichkin S., Surina E., and Wroblewski J.T. J. Med. Chem. 41 (1998) 1641-1650
16. Pellicciari R., Marinozzi M., Costantino G., Natalini B., Moroni F., and Pellegrini D. J. Med. Chem. 42 (1999) 2716-2720
17. Bradley D.M., Mapitse R., Thomson N.M., and Hayes C.J. J. Org. Chem. 67 (2002) 7613-7617
18. Battistini L., Curti C., Zanardi F., Rassu G., Auzzas L., and Casiraghi G. J. Org. Chem. 69 (2004) 2611-2613
19. Baudy R.B., Sze J.Y., and Butera J.A. Synth. Commun. 34 (2004) 3949-3954
20. Ung A.T., Pyne S.G., Batenburg-Nguyen U., Davis A.S., Sherif A., Bischoff F., and Lesage A.S.J. Tetrahedron 61 (2005) 1803-1812
21. Palmer E., Monaghan D.T., and Cotman C.W. Eur. J. Pharmacol. 166 (1989) 585-587
22. Joly C., Gomeza J., Brabet I., Curry K., Bockaert J., and Pin J.-P. J. Neurosci. 15 (1995) 3970-3981
23. Acher F.C., Tellier F.J., Azerad R., Brabet I.N., Fagni L., and Pin J.P.R. J. Med. Chem. 40 (1997) 3119-3129
24. Kawashima N., Karasawa J., Shimazaki T., Chaki S., Okuyama S., Yasuhara A., and Nakazato A. Neurosci. Lett. 378 (2005) 131-134
25. Aghajanian G.K., and Marek G.J. Neuropharmacology 36 (1997) 589-599
26. Marek G.J., Wright R.A., Schoepp D.D., Monn J.A., and Aghajanian G.K. J. Pharmacol. Exp. Ther. 292 (2000) 76-87
27. Martin-Ruiz R., Puig M.V., Celada P., Shapiro D.A., Roth B.L., Mengod G., and Artigas F. J. Neurosci. 21 (2001) 9856-9866
28. Wieronska J.M., Smialowska M., Branski P., Gasparini F., Klodzinska A., Szewczyk B., Palucha A., Chojnacka-Wojcik E., and Pilc A. Neuropsychopharmacology 29 (2004) 514-521
29. Stachowicz K., Chojnacka-Wojcik E., Klak K., and Pilc A. Neuropharmacology 52 (2007) 306-312
30. Caputo F., Clerici F., Gelmi M.L., Pellegrino S., and Pilati T. Tetrahedron: Asymmetry 17 (2006) 61-67
31. Abbiati G., Clerici F., Gambini A., Gelmi M.L., and Pilati T. J. Org. Chem. 65 (2001) 6299-6304
32. Tager H.S., and Christensen H.N. J. Am. Chem. Soc. 94 (1972) 968-972
33. Bueno M.P., Cativiela C., Finol C., and Mayoral J.A. Can. J. Chem. 65 (1987) 2182-2186
34. Cativiela C., Loper P., and Mayoral J.A. Tetrahedron: Asymmetry 2 (1991) 449-456
35. Cativiela C., Loper P., and Mayoral J.A. Tetrahedron: Asymmetry 1 (1990) 379-388
36. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. J. Biol. Chem. 193 (1951) 265-266
37. Dalpiaz A., Borea P.A., Gessi S., and Gilli S. Eur. J. Pharmacol. 312 (1996) 107-114
38. Leysen J.E., Niemergeers C.J., Van Neuten J.M., and Laduron P.M. Mol. Pharmacol. 21 (1982) 301-314